BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12922959)

  • 1. Contribution of the initial features of systemic lupus erythematosus to the clinical evolution and survival of a cohort of Mediterranean patients.
    Buján S; Ordi-Ros J; Paredes J; Mauri M; Matas L; Cortés J; Vilardell M
    Ann Rheum Dis; 2003 Sep; 62(9):859-65. PubMed ID: 12922959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The outcome of patients with renal involvement in pediatric-onset systemic lupus erythematosus--a 20-year experience in Asia.
    Lee PY; Yeh KW; Yao TC; Lee WI; Lin YJ; Huang JL
    Lupus; 2013 Dec; 22(14):1534-40. PubMed ID: 23966304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High genetic risk score is associated with early disease onset, damage accrual and decreased survival in systemic lupus erythematosus.
    Reid S; Alexsson A; Frodlund M; Morris D; Sandling JK; Bolin K; Svenungsson E; Jönsen A; Bengtsson C; Gunnarsson I; Illescas Rodriguez V; Bengtsson A; Arve S; Rantapää-Dahlqvist S; Eloranta ML; Syvänen AC; Sjöwall C; Vyse TJ; Rönnblom L; Leonard D
    Ann Rheum Dis; 2020 Mar; 79(3):363-369. PubMed ID: 31826855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic lupus erythematosus in Greece. Clinical features, evolution and outcome: a descriptive analysis of 292 patients.
    Vlachoyiannopoulos PG; Karassa FB; Karakostas KX; Drosos AA; Moutsopoulos HM
    Lupus; 1993 Oct; 2(5):303-12. PubMed ID: 8305923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic lupus erythematosus in Spanish males: a study of the Spanish Rheumatology Society Lupus Registry (RELESSER) cohort.
    Riveros Frutos A; Casas I; Rúa-Figueroa I; López-Longo FJ; Calvo-Alén J; Galindo M; Fernández-Nebro A; Pego-Reigosa JM; Olivé Marqués A;
    Lupus; 2017 Jun; 26(7):698-706. PubMed ID: 27799439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical importance of positive test results for lupus anticoagulant and anticardiolipin antibodies.
    Proven A; Bartlett RP; Moder KG; Chang-Miller A; Cardel LK; Heit JA; Homburger HA; Petterson TM; Christianson TJ; Nichols WL
    Mayo Clin Proc; 2004 Apr; 79(4):467-75. PubMed ID: 15065611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic lupus erythematosus (SLE) in childhood: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults.
    Font J; Cervera R; Espinosa G; Pallarés L; Ramos-Casals M; Jiménez S; García-Carrasco M; Seisdedos L; Ingelmo M
    Ann Rheum Dis; 1998 Aug; 57(8):456-9. PubMed ID: 9797549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erythematosus.
    Martinez-Berriotxoa A; Ruiz-Irastorza G; Egurbide MV; Garmendia M; Gabriel Erdozain J; Villar I; Aguirre C
    Lupus; 2007; 16(10):810-6. PubMed ID: 17895304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lupus anticoagulant as a prognostic marker in systemic lupus erythematosus.
    Jouhikainen T; Stephansson E; Leirisalo-Repo M
    Br J Rheumatol; 1993 Jul; 32(7):568-73. PubMed ID: 8339126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiphospholipid antibodies and thrombosis in systemic lupus erythematosus: comparison of three lupus anticoagulant assays and anticardiolipin ELISA in 188 patients.
    Jouhikainen T; Julkunen H; Vaarala O; Leirisalo-Repo M; Stephansson E; Vahtera E; Palosuo T; Myllylä G
    Blood Coagul Fibrinolysis; 1992 Aug; 3(4):407-14. PubMed ID: 1420816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticardiolipin antibodies in systemic lupus erythematosus: clinical correlates, HLA associations, and impact on survival.
    Gulko PS; Reveille JD; Koopman WJ; Burgard SL; Bartolucci AA; Alarcón GS
    J Rheumatol; 1993 Oct; 20(10):1684-93. PubMed ID: 8295179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus.
    Manger K; Manger B; Repp R; Geisselbrecht M; Geiger A; Pfahlberg A; Harrer T; Kalden JR
    Ann Rheum Dis; 2002 Dec; 61(12):1065-70. PubMed ID: 12429536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes in juvenile onset lupus: single center cohort from a developing country.
    Aggarwal A; Phatak S; Srivastava P; Lawrence A; Agarwal V; Misra R
    Lupus; 2018 Oct; 27(11):1867-1875. PubMed ID: 30071768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus.
    Somers E; Magder LS; Petri M
    J Rheumatol; 2002 Dec; 29(12):2531-6. PubMed ID: 12465147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of antiphospholipid antibodies in lupus nephritis.
    Natejumnong C; Ruangkanchanasetr P; Aimpun P; Supaporn T
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S121-8. PubMed ID: 17044463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and clinical associations of lupus anticoagulant, anticardiolipin antibodies, and anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus.
    Woo KS; Kim KE; Kim JM; Han JY; Chung WT; Kim KH
    Korean J Lab Med; 2010 Feb; 30(1):38-44. PubMed ID: 20197721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for systemic lupus erythematosus flares in patients with end-stage renal disease: a case-control study.
    Barrera-Vargas A; Quintanar-Martínez M; Merayo-Chalico J; Alcocer-Varela J; Gómez-Martín D
    Rheumatology (Oxford); 2016 Mar; 55(3):429-35. PubMed ID: 26396262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between cerebrovascular and valvular manifestations in a Serbian cohort of patients with antiphospholipid syndrome.
    Djokovic A; Stojanovich L; Stanisavljevic N; Banicevic S; Smiljanic D; Milovanovic B
    Clin Exp Rheumatol; 2018; 36(5):850-855. PubMed ID: 29846156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and immunological aspects and outcome of a Brazilian cohort of 414 patients with systemic lupus erythematosus (SLE): comparison between childhood-onset, adult-onset, and late-onset SLE.
    das Chagas Medeiros MM; Bezerra MC; Braga FN; da Justa Feijão MR; Gois AC; Rebouças VC; de Carvalho TM; Carvalho LN; Ribeiro ÁM
    Lupus; 2016 Apr; 25(4):355-63. PubMed ID: 26405022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.